Teva CEO touts 'defining strength' of innovative drugs as its sales grow for 11th straight quarter
5th November 2025 Uncategorised 0The company remains confident in the continued sales potential of Austedo after wrapping up government negotiations that will change the Medicare price for its top-seller in 2027.
More: Teva CEO touts 'defining strength' of innovative drugs as its sales grow for 11th straight quarter
Source: fierce
